Decreased expression of SOX9 in intraductal papillary mucinous neoplasms of the bile duct

Hepato-Gastroenterology

Volumn 60, Issue 127, 2013, Pages 1573-1576

  Kuroki, Tamotsu ^a   Tanaka, Takayuki ^a   Kitasato, Amane ^a   Adachi, Tomohiko ^a   Ono, Shinichiro ^a   Hirabaru, Masataka ^a   Takatsuki, Mitsuhisa ^a   Eguchi, Susumu ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

Counterpart; IPMN; IPMN B; SOX9

Indexed keywords

ADENOMA; AGED; BILE DUCT NEOPLASMS; BIOPSY; CARCINOMA, PAPILLARY; DOWN-REGULATION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASMS, CYSTIC, MUCINOUS, AND SEROUS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SOX9 TRANSCRIPTION FACTOR; TUMOR MARKERS, BIOLOGICAL;

EID: 84893947977     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: 10.5754/hge13316     Document Type: Article

References (24)

1. Mercadier M, Bodard M, Fingerhut A, et al.: Papillomatosis of the intrahepatic bile ducts. World J Surg 1984; 8:30-35. (Pubitemid 15017719)
2. Wu SD, Lu CD, Lu CJ, et al.: Mucin-producing intrahepatic biliary papillomatosis. Surg Today 2010; 40:845-850.
3. Nakanuma Y, Zen Y, Harada K, et al.: Tumorigenesis and phenotypic characteristics of mucin-producing bile duct tumors: an immunohistochemical approach. J Hepatobiliary Pancreat Sci 2010; 17:211.
4. Yeh TS, Tseng JH, Chiu CT, et al.: Cholangiographic spectrum of intraductal papillary mucinous neoplasm of the bile ducts. Ann Surg 2006; 244:248.
5. Paik KY, Heo JS, Choi SH, et al.: Intraductal papillary neoplasm of the bile ducts: the clinical features and surgical outcome of 25 cases. J Surg Oncol 2008; 97:508.
6. Chen TC, Nakanuma Y, Zen Y, et al.: Intraductal papillary neoplasia of the liver associated with hepatolithiasis. Hepatology 2001; 34:651.
7. Abraham SC, Lee JH, Hruban RH, et al.: Molecular and immunohistochemical analysis of intraductal papillary neoplasms of the biliary tract. Human Pathol 2003; 34:902.
8. Zen Y, Fujii T, Itatsu K, et al.: Biliary papillary tumors share pathological features with intraductal papillary mucinous neoplasm of the pancreas. Hepatology 2006; 44:1333.
9. Shibahara H, Tamada S, Goto M, et al.: Pathologic features of mucin-producing bile duct tumors: two histopathologic categories as counterparts of pancreatic intraductal papillary mucinous neoplasms. Am J Surg Pathol 2004; 28:327.
10. Ji Y, Fan J, Zhou J, et al.: Intraductal papillary neoplasms of bile duct. A distinct entity like its counterpart in pancreas. Histol Histopathol 2008; 23:41.
11. Lu B, Fang Y, Xu J et al.: Analysis of SOX9 expression in colorectal cancer. Am J Clin Pathol 2008; 130:897.
12. Zhou CJ, Guo JQ, Zhu KX, et al.: Elevated expression of SOX9 is related with the progression of gastric carcinoma. Diagn Cytopathol 201; 39:105.
13. Kimura M, Mutoh H, Sugano K: SOX9 is expressed in normal stomach, intestinal metaplasia, and gastric carcinoma in humans. J Gastroenterol 2011; 46:1292.
14. Antoniou A, Raynaud P, Cordi S, et al.: Intrahepatic bile ducts develop according to a new mode of tubulogenesis regulated by the transcription factor SOX9. Gastroenterology 2009; 136:2325.
15. Tanaka T, Kuroki T, Adachi T, et al.: The evaluation of SOX9 expression in pancreatic cancer and intraductal papillary mucinous neoplasm. Pancreas 2013; 42(3):488-493.
16. Martin RC, Klimstra DS, Schwartz L, et al.: Hepatic intraductal oncocytic papillary carcinoma. Cancer 2002; 95:2180.
17. Rouzbahman M, Serra S, Adsay NV, et al.: Oncocytic papillary neoplasms of the biliary tract: a clinicopathological, mucin core and Wnt pathway protein analysis of four cases. Pathology 2007; 39:413.
18. Foster JM, Dominguez-Steglich MA, Guioli S, et al.: Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene. Nature 1994; 372:525.
19. Sponkony RF, Aoki Y, Saint-Germain N, et al.: The transcription factor SOX9 is required for cranial neural crest development in Xenopus. Development 2002; 129:421.
20. Furuyama K, Kawaguchi Y, Akiyama H, et al.: Continuous cell supply from a Sox9-expressing progenitor zone in adult liver, exocrine pancreas, and intestine. Nat Genet 2011; 43:34.
21. Sun M, Uozaki H, Hino R, et al.: SOX9 expression and its methylation status in gastric cancer. Virchows Arch 2012; 460:271.
22. Lu B, Fang Y, Xu J, et al.: Analysis of SOX9 expression in colorectal cancer. Am J Clin Pathol 2008; 130:897.
23. Passeron T, Valencia JC, Namiki T, et al.: Upregulation of SOX9 inhibits the growth of human and mouse melanomas and restores their sensitivity to retinoic acid. J Clin Invest 2009; 119:954.
24. Mazur PK, Riener MO, Jochum W, et al.: Expression and clinicopathological significance of Notch signaling and cell-fate genes in biliary tract cancer. Am J Gastroenterol 2011; 107:126.